SG10202102365XA - Composition for suppressing or improving eye fatigue - Google Patents

Composition for suppressing or improving eye fatigue

Info

Publication number
SG10202102365XA
SG10202102365XA SG10202102365XA SG10202102365XA SG10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA
Authority
SG
Singapore
Prior art keywords
suppressing
composition
eye fatigue
improving eye
improving
Prior art date
Application number
SG10202102365XA
Inventor
Toshihide Kurihara
Yuji Morita
Kenta JONAI
Daisuke Fujiwara
Original Assignee
Kirin Holdings Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Holdings Kk filed Critical Kirin Holdings Kk
Publication of SG10202102365XA publication Critical patent/SG10202102365XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10202102365XA 2016-09-09 2017-09-08 Composition for suppressing or improving eye fatigue SG10202102365XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016177039 2016-09-09

Publications (1)

Publication Number Publication Date
SG10202102365XA true SG10202102365XA (en) 2021-04-29

Family

ID=61562181

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10202102365XA SG10202102365XA (en) 2016-09-09 2017-09-08 Composition for suppressing or improving eye fatigue

Country Status (6)

Country Link
US (3) US11389494B2 (en)
EP (1) EP3511011A4 (en)
JP (2) JP6640803B2 (en)
CA (1) CA3036197C (en)
SG (1) SG10202102365XA (en)
WO (1) WO2018047930A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7049397B2 (en) * 2020-06-10 2022-04-06 キリンホールディングス株式会社 Composition for suppressing or improving depression
EP4119151A4 (en) * 2021-06-03 2023-10-25 MD Healthcare Inc. Composition for preventing or treating eye diseases comprising extracellular vesicles derived from lactobacillus paracasei

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE421256T1 (en) * 2003-03-13 2009-02-15 Kirin Holdings Kk PROBIOTIC COMPOSITION
US20090312438A1 (en) 2008-06-13 2009-12-17 Bernstein Paul S Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium
US20130302380A1 (en) * 2010-12-28 2013-11-14 Daisuke Fujiwara Agent for inducing interferon production containing lactic acid bacteria
CN105025909B (en) * 2013-02-27 2020-05-19 株式会社明治 Stress-reducing agent
CN111821333A (en) 2015-07-13 2020-10-27 东北泰克诺亚奇股份有限公司 Composition for protecting optic nerve
IT201600081929A1 (en) 2016-08-03 2018-02-03 St Europeo Di Oncologia S R L USE OF THE LACTOBACILLUS PARACASEI SURNATANT IN THE TREATMENT OF CONJUNCTIVITY, IN PARTICULAR OF THE VERNAL CHERATOCONGIUNTIVITE

Also Published As

Publication number Publication date
US11890309B2 (en) 2024-02-06
US20240180979A1 (en) 2024-06-06
EP3511011A1 (en) 2019-07-17
CA3036197C (en) 2023-02-28
US11389494B2 (en) 2022-07-19
JP2020063297A (en) 2020-04-23
JP2018043986A (en) 2018-03-22
JP6975769B2 (en) 2021-12-01
US20220323516A1 (en) 2022-10-13
US20190374587A1 (en) 2019-12-12
JP6640803B2 (en) 2020-02-05
WO2018047930A1 (en) 2018-03-15
EP3511011A4 (en) 2020-03-04
CA3036197A1 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
HK1253915A1 (en) Composition for surface modification
IL249643A0 (en) Ophthalmic composition
LT3426226T (en) Ophthalmologic composition
PL3373973T3 (en) Ocular compositions
HUE049036T2 (en) Compositions and tools for treating glaucoma
PT3721868T (en) Ophthalmic suspension composition
PL3145511T3 (en) Composition for treating the eye
SG11201707117SA (en) Ophthalmic composition
PL3273947T3 (en) Composition for ocular health
GB201619525D0 (en) Ophthalmic composition
HK1254371A1 (en) Viscoelastic composition
SG10202102365XA (en) Composition for suppressing or improving eye fatigue
HK1247088A1 (en) Composition for improving brain function
SG11201706794XA (en) Fatigue improvement agent
LT3519050T (en) Compositions for treating ophthalmic conditions
PL3446682T3 (en) Ophthalmic composition
ZA201703701B (en) Ophthalmic composition
PL3303486T3 (en) Surface treatment composition
PT3470059T (en) Ophthalmic suspension composition